Enovix director granted 29,104 restricted shares

Enovix Corp director Joseph Ian Malchow reported an equity grant of 29,104 shares of common stock at no cost, classified as a grant/award acquisition.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Enovix Corp director Joseph Ian Malchow reported an equity grant of 29,104 shares of common stock at no cost, classified as a grant/award acquisition. Following this award, his directly held common stock position is 467,367 shares.

Footnotes explain these are shares issuable upon settlement of restricted stock units, each equal to one Enovix common share. The RSUs vest in four 25% installments on September 11, 2026, December 11, 2026, March 11, 2027 and June 11, 2027 (or the 2027 annual meeting reference date), subject to continued service. The filing also notes 1,300 shares held indirectly for a minor child.

Insider Trade Summary

Grant/Award: 29,104 shares

Grant/Award 3 txns

Insider Malchow Joseph Ian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,104	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 471,767 shares (Direct); Common Stock — 1,300 shares (Indirect, Minor Child)

Footnotes (4)

F1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
F2. Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person.
F3. Shares held by Reporting Person and spouse JTWROS.
F4. Shares held by minor child.

Key Figures

Equity grant size: 29,104 shares Grant price: $0.0000 per share Direct holdings after grant: 467,367 shares +3 more

6 metrics

Equity grant size 29,104 shares Common stock grant/award acquisition on June 11, 2026

Grant price $0.0000 per share Reported price for 29,104-share equity grant

Direct holdings after grant 467,367 shares Total Enovix common stock directly held following transactions

Indirect minor child holdings 1,300 shares Enovix common stock held indirectly for a minor child

RSUs included in holdings 30,766 shares Shares issuable upon settlement of RSUs previously granted

RSU vesting tranches 4 installments of 25% Scheduled on Sep 11, 2026; Dec 11, 2026; Mar 11, 2027; Jun 11, 2027/2027 meeting date

Key Terms

restricted stock units ("RSUs"), contingent right, vest, settlement of RSUs, +1 more

5 terms

restricted stock units ("RSUs") financial

"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vest financial

"25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027..."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settlement of RSUs financial

"Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person."

JTWROS financial

"Shares held by Reporting Person and spouse JTWROS."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enovix (ENVX) director Joseph Ian Malchow report in this Form 4?

He reported receiving 29,104 Enovix common shares as an equity grant at no cost. These are tied to restricted stock units and increase his directly held position to 467,367 shares, reflecting routine director compensation rather than an open-market stock purchase or sale.

How many Enovix (ENVX) shares did Malchow acquire and at what price?

Malchow was granted 29,104 shares of Enovix common stock at a reported price of $0.0000 per share. The grant is compensation-related, delivered via restricted stock units that convert into common shares as they vest over the stated schedule.

What is the vesting schedule for Malchow’s Enovix restricted stock units?

The RSUs vest in four equal 25% installments tied to specific dates. Vesting occurs on September 11, 2026, December 11, 2026, March 11, 2027 and June 11, 2027 or the 2027 annual meeting reference date, contingent on Malchow’s continuous board service.

How many Enovix (ENVX) shares does Malchow hold after this Form 4 grant?

After the reported grant, Malchow directly holds 467,367 Enovix common shares. The filing also notes 1,300 shares held indirectly for a minor child. A separate footnote states 30,766 of his total holdings are issuable upon settlement of previously granted RSUs.

Are Malchow’s Enovix (ENVX) RSUs already common shares or future issuable stock?

They represent future issuable stock upon settlement of restricted stock units. Each RSU gives a contingent right to receive one Enovix common share. Settlement occurs as the RSUs vest on the scheduled dates, assuming Malchow continues his service as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 09:33 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malchow Joseph Ian

(Last)

(First)

(Middle)

C/O ENOVIX CORPORATION

3501 W WARREN AVENUE

(Street)

FREMONT

CALIFORNIA

94538

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		A		29,104⁽¹⁾	A	$0	467,367⁽²⁾	D
Common Stock								4,400	D⁽³⁾
Common Stock								1,300	I⁽⁴⁾	Minor Child

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.

2. Includes 30,766 shares issuable upon the settlement of RSUs granted to the Reporting Person.

3. Shares held by Reporting Person and spouse JTWROS.

4. Shares held by minor child.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Joseph Malchow	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR